BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38597722)

  • 21. High-risk HPV-related Squamous Cell Carcinoma in the Conjunctiva and Lacrimal sac: Clinicopathologic Characteristics and Diagnostic Utility of p16 and Rb Immunohistochemistry.
    Hongo T; Yamamoto H; Tanabe M; Yasumatsu R; Kuga R; Miyazaki Y; Jiromaru R; Hashimoto K; Tateishi Y; Sonoda KH; Nakagawa T; Oda Y
    Am J Surg Pathol; 2022 Jul; 46(7):977-987. PubMed ID: 34985048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center.
    Rosenbaum E; Antonescu CR; Smith S; Bradic M; Kashani D; Richards AL; Donoghue M; Kelly CM; Nacev B; Chan JE; Chi P; Dickson MA; Keohan ML; Gounder MM; Movva S; Avutu V; Thornton K; Zehir A; Bowman AS; Singer S; Tap W; D'Angelo S
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35365586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma.
    Gregoire L; Cubilla AL; Reuter VE; Haas GP; Lancaster WD
    J Natl Cancer Inst; 1995 Nov; 87(22):1705-9. PubMed ID: 7473819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
    Cho RJ; Alexandrov LB; den Breems NY; Atanasova VS; Farshchian M; Purdom E; Nguyen TN; Coarfa C; Rajapakshe K; Prisco M; Sahu J; Tassone P; Greenawalt EJ; Collisson EA; Wu W; Yao H; Su X; Guttmann-Gruber C; Hofbauer JP; Hashmi R; Fuentes I; Benz SC; Golovato J; Ehli EA; Davis CM; Davies GE; Covington KR; Murrell DF; Salas-Alanis JC; Palisson F; Bruckner AL; Robinson W; Has C; Bruckner-Tuderman L; Titeux M; Jonkman MF; Rashidghamat E; Lwin SM; Mellerio JE; McGrath JA; Bauer JW; Hovnanian A; Tsai KY; South AP
    Sci Transl Med; 2018 Aug; 10(455):. PubMed ID: 30135250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
    Facompre ND; Rajagopalan P; Sahu V; Pearson AT; Montone KT; James CD; Gleber-Netto FO; Weinstein GS; Jalaly J; Lin A; Rustgi AK; Nakagawa H; Califano JA; Pickering CR; White EA; Windle BE; Morgan IM; Cohen RB; Gimotty PA; Basu D
    Int J Cancer; 2020 Dec; 147(11):3236-3249. PubMed ID: 32478869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma.
    Chahoud J; Gleber-Netto FO; McCormick BZ; Rao P; Lu X; Guo M; Morgan MB; Chu RA; Martinez-Ferrer M; Eterovic AK; Pickering CR; Pettaway CA
    Clin Cancer Res; 2021 May; 27(9):2560-2570. PubMed ID: 33441293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of discordant human papillomavirus and p16 oropharyngeal squamous cell carcinomas in an African American cohort.
    Liu JC; Parajuli S; Blackman E; Gibbs D; Ellis A; Hull A; Beck JR; Giri V; Iherjirka P; Khurana JS; Ragin CR
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E867-72. PubMed ID: 25962720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes.
    Lazo de la Vega L; Bick N; Hu K; Rahrig SE; Silva CD; Matayoshi S; Picciarelli P; Wang X; Sugar A; Soong HK; Mian SI; Robinson DR; Chinnaiyan AM; Demirci H; Daniels AB; Worden F; Eberhart CG; Tomlins SA; Rao RC; Harms PW
    Mod Pathol; 2020 Nov; 33(11):2280-2294. PubMed ID: 32461624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinoma.
    Yu JJ; Fu P; Pink JJ; Dawson D; Wasman J; Orem J; Mwanda WO; Zhu H; Liang X; Guo Y; Petros WP; Mitsuyasu RT; Wabinga H; Remick SC
    PLoS One; 2010 May; 5(5):e10477. PubMed ID: 20498858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder.
    Necchi A; Madison R; Raggi D; Jacob JM; Bratslavsky G; Shapiro O; Elvin JA; Vergilio JA; Killian JK; Ngo N; Ramkissoon S; Severson E; Hemmerich AC; Huang R; Ali SM; Chung JH; Reddy P; Miller VA; Schrock AB; Gay LM; Alexander BM; Grivas P; Ross JS
    Eur Urol; 2020 Apr; 77(4):548-556. PubMed ID: 31959546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esophageal squamous cell carcinoma with basaloid features are genetically and prognostically similar to conventional squamous cell carcinoma.
    Sauer MA; Yang J; Isidro RA; Dong F; Patil DT; Wee JO; Agoston AT; Deshpande V; Zhao L
    Mod Pathol; 2022 Sep; 35(9):1247-1253. PubMed ID: 35351978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma.
    Ottenhof SR; Djajadiningrat RS; Thygesen HH; Jakobs PJ; Jóźwiak K; Heeren AM; de Jong J; Sanders J; Horenblas S; Jordanova ES
    Front Immunol; 2018; 9():1253. PubMed ID: 29942303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TERT promoter mutations in penile squamous cell carcinoma: high frequency in non-HPV-related type and association with favorable clinicopathologic features.
    Kim SK; Kim JH; Han JH; Cho NH; Kim SJ; Kim SI; Choo SH; Kim JS; Park B; Kwon JE
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1125-1135. PubMed ID: 33635430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer.
    Shi Y; Lei Y; Liu L; Zhang S; Wang W; Zhao J; Zhao S; Dong X; Yao M; Wang K; Zhou Q
    Cancer Med; 2021 Apr; 10(7):2216-2231. PubMed ID: 33655698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer.
    Negrao MV; Skoulidis F; Montesion M; Schulze K; Bara I; Shen V; Xu H; Hu S; Sui D; Elamin YY; Le X; Goldberg ME; Murugesan K; Wu CJ; Zhang J; Barreto DS; Robichaux JP; Reuben A; Cascone T; Gay CM; Mitchell KG; Hong L; Rinsurongkawong W; Roth JA; Swisher SG; Lee J; Tsao A; Papadimitrakopoulou V; Gibbons DL; Glisson BS; Singal G; Miller VA; Alexander B; Frampton G; Albacker LA; Shames D; Zhang J; Heymach JV
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34376553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay.
    Cubilla AL; Lloveras B; Alejo M; Clavero O; Chaux A; Kasamatsu E; Velazquez EF; Lezcano C; Monfulleda N; Tous S; Alemany L; Klaustermeier J; Muñoz N; Quint W; de Sanjose S; Bosch FX
    Am J Surg Pathol; 2010 Jan; 34(1):104-14. PubMed ID: 20035150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
    Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma.
    Portugal LG; Goldenberg JD; Wenig BL; Ferrer KT; Nodzenski E; Sabnani JB; Javier C; Weichselbaum RR; Vokes EE
    Arch Otolaryngol Head Neck Surg; 1997 Nov; 123(11):1230-4. PubMed ID: 9366703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes.
    Lee DJ; Eun YG; Rho YS; Kim EH; Yim SY; Kang SH; Sohn BH; Kwon GH; Lee JS
    Oral Oncol; 2018 Oct; 85():44-51. PubMed ID: 30220319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.